Latest Conference Articles

In a new podcast episode, Daniel George, M.D., Brian Helfand, M.D., Ph.D., and Ashesh Jani, M.D., discussed recent study findings presented at the ASCO-GU symposium, directions for future research and emerging trends in molecular imaging that may help advance precision medicine for patients with prostate cancer.

Initial breast cancer risk scoring with adjunctive AI assessment of screening mammograms increased by approximately 80 percent in a subsequent screening round for women with breast cancer, according to research findings presented at the European Congress of Radiology.

While large language models (LLMs) may offer the promise of workflow efficiencies and streamlined documentation in radiology, LLMs may also increase exposure to cybersecurity risks, according to a presentation at the European Congress of Radiology (ECR).

Combining an 85 cm bore, high resolution and accelerated image reconstruction, the Rembra CT platform can reportedly handle up to 270 CT exams a day.

In a recent interview, Ashesh Jani, M.D., discussed pertinent findings in two post-hoc studies from the SPOTLIGHT trial that examined the efficacy of 18F-flotufolastat PET/CT for detecting biochemical recurrence and bone metastases in patients with prostate cancer.

In a recent interview, Brian Helfand, M.D., Ph.D., discussed key findings from a multicenter prospective trial, presented at the ASCO-GU symposium, that compared the PET radiotracers 18F-flotufolastat and 18F piflufolastat for urinary radioactivity and detection of PCa recurrence.

In a recent interview from the ASCO-GU conference. Daniel George, M.D., discussed new study findings with 177Lu-PSMA-617 for the treatment of older taxane-naïve patients with metastatic castration-resistant prostate cancer (mCRPC) and potential implications for future research.

In comparison to 68Ga-PSMA-11, 64Cu-SAR-bisPSMA more than doubled the rate of detection for prostate cancer recurrence and facilitated changes to the treatment plan in 44 percent of patients, according to research to be presented at the upcoming European Association of Urology (EAU) Congress.

In a recent interview from the International Stroke Conference, Jeremy Heit, M.D., Ph.D., discussed new research suggesting that AI may offer better assessment than neuroradiologists of aneurysm growth on computed tomography or magnetic resonance angiography scans.

Catch up on the latest CT, MRI, ultrasound and PET imaging research from the recent RSNA conference.

In a reeent interview, Jenifer Pitman, M.D., discussed key findings from a large knee MRI study, presented at the RSNA conference, which demonstrated significant gender differences with ACL, MCL and medial meniscal injuries.

In a comparative study presented at the recent RSNA conference, researchers found that the combination of capsular contact length from MRI and SUVmax data from PSMA PET/CT yielded greater than 80 percent sensitivity and specificity for extraprostatic extension.

In an interview at the recent RSNA conference, Sriyesh Krishnan, M.D., discussed pertinent principles in assessing AI models, ongoing monitoring of the adjunctive value and an unyielding focus on patient care.

In a recent interview at the RSNA conference, neuroradiologist Emanuel Kanal, M.D., discussed key findings from a committee of the American Board of Magnetic Resonance Safety with respect to MRI technologist responsibilities and how the advent of remote MRI scanning and related protocols may lead to increased MRI safety.

Catch up on the latest research and insights from Constance Lehman, M.D., Rajesh Bhayana, M.D., Stamatia Destounis, M.D., and more with Diagnostic Imaging interviews from the recent RSNA conference.

In a recent interview, Tyler Coombes, M.D., and Parth Patel, M.D., discussed recent research, presented at the RSNA conference, which suggested that quantitative evaluation of non-calcified plaque volume (NCPV) may offer significant utility for cardiovascular risk stratification.

Whether it was a new advance in 3T MRI, emerging mammography-based AI technology, promising enterprise imaging platforms or new ultrasound devices, here is a recap of some of the product innovations launched or showcased at the annual RSNA conference.

Noting limitations of prostate MRI and advantages of PSMA PET/CT for detecting extraprostatic extension and lymph node involvement, researchers explored the potential utility of standalone PSMA PET/CT in prostate cancer staging in a review presented for the RSNA conference.

Reviewing an array of study presentations from the recent RSNA meeting, this author discusses insights from emerging research, ranging from the use of large language models (LLMs) in radiology reports to the potential impact of LLM assistance in differential diagnosis for brain MRIs.

In a recent interview at the RSNA conference, Rajesh Bhayana, M.D., discussed current research findings on the use of large language models (LLMs) in radiology and emerging LLMs that may have an impact.

In a recent interview at the RSNA conference, Roland Rott shared his perspective on the planned acquisition of Intelerad by GE HealthCare along with insights on key synergies and future directions.

In a recent interview at the RSNA conference, Manisha Bahl, M.D., discussed new research examining the use of slab reconstruction technology with digital breast tomosynthesis (DBT), and its potential in reducing interpretation time and imaging volume.

In a recent interview at the RSNA conference, Talissa Altes, M.D., and Konstanze Diefenbach, M.D., discussed the potential utility and recent research findings on the use of the MRI contrast agent gadoquatrane for pediatric patients.

For men with a 1 μg/m3 increase in ten-year exposure to fine particulate matter, a common air pollutant, there was a 47 increased likelihood of moving to a higher CAD-RADS stenosis category, according to new coronary CT angiography research presented at the Radiological Society of North America (RSNA) conference.

Absent flow to perforator vessels in the face occurred in over 40 percent of women who had cosmetic fillers, according to new vascular ultrasound research presented at the RSNA conference.

The Resona A20 device reportedly provides advances in imaging and AI automation along with an intuitive ergonomic design for ease of use.

In a recent interview at the RSNA conference, Constance Lehman, M.D., Ph.D., discussed new research, which compared image-based AI for mammography versus breast density assessment in evaluating breast cancer risk.

The addition of ClearCEM to Mammomat B.brilliant devices reportedly enhances differentiation of suspicious areas in image reconstruction and facilitates improved accuracy with tomosynthesis-guided biopsies.